ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000953.1|Amicetin_1 # 3 # 323 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.679	BGC0000953.1|Amicetin_1 	3	323	+	Loose	1080	25.0238	rosB	42.86	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	CGATTCCAGCGAGGCGACATCGCCGACCACGCCACGGAGTCCAGGCGCCGGTCCATGGTTGCGGAGGCGTCCGGCCTGGCGCGCTGCCACGAGATCCACTCCGCGGTGCACGCGGAGGAGGGCGGTAGGTTCCGCGGGGCCGTCTCCGTGTACCAGCTGGGCCTGTTCGCCGACGCCCCCGAGGGGCAGCTGCCCGGTCGGTGGATCTCACTGAAAGAGGTGGAACGGCTCGTTCAAGGCGGTGACCGGCTCAGCGTCGAGCTGCGTACCTGCCTGACGATGATCAAAGGTCTCCTCACGATCGGAGCCCTCAAACCATGA	RFQRGDIADHATESRRRSMVAEASGLARCHEIHSAVHAEEGGRFRGAVSVYQLGLFADAPEGQLPGRWISLKEVERLVQGGDRLSVELRTCLTMIKGLLTIGALKP	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	18.83	gnl|BL_ORD_ID|466|hsp_num:0	507			1224	1308	polymyxin B; polymyxin B1; polymyxin B2; polymyxin B3; polymyxin B4
BGC0000953.1|Amicetin_2 # 320 # 1288 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.717	BGC0000953.1|Amicetin_2 	320	1288	+	Loose	500	25.409	aadK	28.12	3002627	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGATCGCGGCGATAGGCAACTCCGAGTACCTGAGCCGCCGGACAGCACCTCTGCTCCGGGAGCTGAACGGCACGGACGCTCCCCTCCTGGTGGGTACCGACCACCCGAGCGGGGCGCGTGCGGCCGCACGCGCCGAGGGGGTCGAGATCATCGATCGCGACGCGGTGCTGTCCGCCCCGGACGTCGACGCCGTCTACGTCTCCAGCGCGACGGGGCGTCACTTCGACGACTGCAGTGCAGCCCTGGCCGCCGGAAAGCACGTGCTGGTGGAGAAGCCGGTCTGTCTGACGGCCGCCGAAGCCCGCGCGCTGGACTCGATGGCCCGTGCCCGGGACCTCACGGTCTTTGAGTGCCTCTCCTACCCGTACCACCCCGCCTGGACCACATTCCTCGCCGAGGTGCGCGCCGCGGCCTGGTCAGGTCCCGTGTCCGTGTCCGCCGTGTTCCGCATACCCGGACGGGAACCCACGGACTTCCGCCGGCACCCGCGCCACGGTAGGGCGGCAGCGGACCTGGGGACCTACTGCCTCGACGCGCTGGTGAGGCTCGGCGCCGCTGCCGAAGACCTCCGCATCGGTGCAATGCTGCTCGAGGACGTGGAAGCCGACGGCGGCGTGGCGGTCGCGAGCCGGCCGGTGGACGGGCACACCTTCACCTACACCGGTACGTGGACCATCGGCGACACCTACGCCAACGCTGTCGTCGTTGCGGACCGTCGGCGGCGCCTCGAACTGCTGCGGGTGTTCTCGCCCCCGGTGGACGCGCCACGCCAGGTCGTCGAGAGAAGGCCGGGCGCACCCGAACCGGCCGTCGTCGCGACCAGCGAACCGGTGAACGCCACACGCGCGTGCCTGACCGCGGGCGCCAGACACCTGCGGGACATGGGCACGGCGGGTCTGGTCGGCTGTTCAGCCCTCGTGCGCCGCATCGCCGCGCTCGAAGGAGCGACGGCGGCCCTTCCCGCTTAG	MIAAIGNSEYLSRRTAPLLRELNGTDAPLLVGTDHPSGARAAARAEGVEIIDRDAVLSAPDVDAVYVSSATGRHFDDCSAALAAGKHVLVEKPVCLTAAEARALDSMARARDLTVFECLSYPYHPAWTTFLAEVRAAAWSGPVSVSAVFRIPGREPTDFRRHPRHGRAAADLGTYCLDALVRLGAAAEDLRIGAMLLEDVEADGGVAVASRPVDGHTFTYTGTWTIGDTYANAVVVADRRRRLELLRVFSPPVDAPRQVVERRPGAPEPAVVATSEPVNATRACLTAGARHLRDMGTAGLVGCSALVRRIAALEGATAALPA	MRSEQEMMDIFLDFALNDERIRLVTLEGSRTNRNIPPDNFQDYDISYFVTDVESFKENDQWLEIFGKRIMMQKPEDMELFPPELGNWFSYIILFEDGNKLDLTLIPIREAEDYFANNDGLVKVLLDKDSFINYKVTPNDRQYWIKRPTAREFDDCCNEFWMVSTYVVKGLARNEILFAIDHLNEIVRPNLLRMMAWHIASQKGYSFSMGKNYKFMKRYLSNKEWEELMSTYSVNGYQEMWKSLFTCYALFRKYSKAVSEGLAYKYPDYDEGITKYTEGIYCSVK	113.38	gnl|BL_ORD_ID|386|hsp_num:0	426			369	465	streptomycin
BGC0000953.1|Amicetin_3 # 1450 # 2223 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.658	BGC0000953.1|Amicetin_3 	1450	2223	+	Loose	400	26.9498	tetB(P)	29.73	3000195	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGGGGCAACGAACCCTGTCCATGGACGAGTCGCCGGAATCGTGCTCGTAGGAGGCACCGGATCACGGCTGTTTCCGGCGACCCGCGTTGTCAACAAACATCTGCTTCCGGTGTATGACAAACCCGCCATCGCGTTCTCCATGGACGTGATGAAGGAATGCGGCGTCAATACGCTGGTCCTCGTCTGCAACGCGGCGGATGAGGAGATATACCGGAGCATCCCGGCCTGGCTCGGATACGCCGACATCGACATCCGCACGGTGGTCCAGGAAGAGCCGAACGGCATCGCGGGCGCCATCGCCTGCGCCCGCGAACACCTGGAACCCGAAGGGTACGAGCGCATCGTCGTCGCGCTCGGGGACACACTCTACGTGCACAGCTCGACCTGGGCGGGAGACATCCTCAGGAAGACCGACGCCACCGGATGCAGCGCCGCGGTCGCGGTCATCGAGCACCCCGACCCGAAGGACTTCGGGGTCGTCGAGAGCACTGCGAACGGAAACGTCGTCCGGGTCAGGGAAAAGGCCAATGTGCGGCACAGCAGCCAGGTCTGCACCGGCCTCTACTCCTTCGACAGCTCCATGTGGAAGCGGCTCGAGTCCATCGTGCCCTCACGCCGCGGCGAACTGGAGATCACGTCACTCCTCGAGTCGTACATCGACGACGGAGGCCTCACCGCGGTGGCCGTGCCCGAGGAGGCCGGATGGTTCGACGTGGGCACGCCCGACCGCCTCGTCGACGCCGCGGTCGCCCGCCGGCGTCTGCTCGCCTGA	MGATNPVHGRVAGIVLVGGTGSRLFPATRVVNKHLLPVYDKPAIAFSMDVMKECGVNTLVLVCNAADEEIYRSIPAWLGYADIDIRTVVQEEPNGIAGAIACAREHLEPEGYERIVVALGDTLYVHSSTWAGDILRKTDATGCSAAVAVIEHPDPKDFGVVESTANGNVVRVREKANVRHSSQVCTGLYSFDSSMWKRLESIVPSRRGELEITSLLESYIDDGGLTAVAVPEEAGWFDVGTPDRLVDAAVARRRLLA	MKKIINIGIVAHVDAGKTTITENLLYYSGAIKSVGRVDLGNTQTDSMELERKRGITIKSSTISFNWNNVKVNIIDTPGHVDFISEVERSLNSLDGAILVISGVEGIQSQTRILFDTLKELNIPTIIFVNKLDRIGANFNKVFEEIKKNMSNKVVRLQEVYDVGSKAVYIKKLFDTCIINDDAINVLSDLDEAFLERYIGGIEPDKEEIQEKLSLYAREGSLYPVFCGAAAIGLGIEDLLDGICSYFPFASNDCESDLSGVVFKIERTSKNEKKVYVRLFGGKISVRDKIQVPNKEIAEKVKKINRLENGGVVEAQRIEAGDIGILYGLTSFQVGDVIGISNDKIKNISIAKPALKTTISAIDKEKNPELFKALTLLAEEDPLLAFAMNDIDKEIYVNLFGEVQMEILSSMLDDLYGIKVEFSNIETIYKETPKGFGASIMHMQEDLNPFWATVGLEIEPAGRGEGLRYISNVSVGSLPKSFQNAIEEAVIKTSKQGLFGWEVTDVKVTLSCGEFFSPASTPADFRNVTPMVFMEALYKAQTVLLEPLHEFELKIPQNALSKAVWDLETMRATFDNPIVIGDEFSIKGLIPVENSKEYKMKIASYTEGRGMFVTKFYGYKEASAEFSKARKKTTYDPLNKKEYLLHKLNAIRD	39.42	gnl|BL_ORD_ID|737|hsp_num:0	804			1134	1344	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000953.1|Amicetin_4 # 2264 # 3670 # 1 # ID=1_4;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.665	BGC0000953.1|Amicetin_4 	2264	3670	+	Loose	275	30.8018	AAC(6')-Iaj	32.69	3003677	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGCTTCAGCAGGACAGCAACCTCACCTCGTCCGACGGGGTCGACGACATCGTCATCCGGGACGCCACGGAAGCCGACCGCGCGGTCATCCAGGGGCTCCTGCACGGTTCCCTCAGGAGGAACTACGACGGAGACCACGTGGCCCAGGCCGACCGCATCATCGACGCCCATCTCGGGGGTGGCAAGGACCCCGTGGGCCATTTCTCGAAGACGCAGCACGTATACGTCGCCGAGTCCGGCGGCGAGGTTGTGGGCGTGATGAACATAGCCGAGAAGCGCCAGGGCACGATGAAGATCAGCCCGCTCATCGTCAACCCCGACTTCCGGGGCTCCAAGGGCGCCGGGTCGGCGCTGCTCGCCAAGTCCGTCGAGGTGGCCAGGGCCCGCGGCGTCCGACAGCTCTACGGCACTGTCGCCGAGCCGAGCTCCTGGATCGAGACGTTCTACCTGAACCGCGGTTGGACCTGCGGCTCGCAGTCGAACAGCCAGTACCGCCCGGGCGTCGTCGAGCACGCCATCTACTACAACGTCGACGACACGGCCGCCACGGCGAGCGAGCCGCTGAAGTTCGAGGAGTACTCCCCGTCGAAGTACGAAGAACTCGAACGGTTCCTGACCTCGCGCATGGACGTCTTCGTCGACGGCATCGACGAGGAATTCGTCCGCGCCCTGGTGGCCGGGCACGAGCGCCGCGGCACACGCGAGGTGGAGGCCAAGTACAAGGAGATCTACCTCGGCTACGAGTCCGGCGTCCTCAGCTCGGTCATCGCGTTCGGGCCGAAGAAGGGCGGCGCGGTCAAGCTGATGCCGCTGAGCGCGACCTCGCAGGACGCGCTGCGGCAGACCCTCCGGTTCGCGCAGTCCTGGGCCGAGGGACGTACCCACAAGCTGTACACGCACCAGCACGTCGACCCTGCGGTGGTGACGGCCTTCCAGAGCGAGATGTGGACCCTCGAAGGACTGCTCCCGGAGGCGTACGCGGCGGACAAGGTGGCCGCCCAGTGGGGATGGCTGCCTGGCGAGACCACCCACCTGGGCCGCAACTCAGACCGCCTGAAGGCCTACACCGAACGTTTCCTGACCTTCGTACAGGACCGTGGCTGGGACCGGATCGAAGAGGCGCGCAGCCTCGCCATGGCGGTCGGCGGCGAGGCCGGCGAGCTGCTGGCCGAACTCCAGTGGCTCAGTGAGACCGAGGTCGTCGAACTGCTGCGCATGGACCGAGAGTTCAAAACCCGGGTGTCGTTCGAGGCCGCCGACATCCTTAACTACCTGATCAGGCTGGCACGGTACTGCGAATTCGACCTGATCGAGGCGGCGGACAAGAAGCTGGCCGTCAACATTGACCGCTTCCCGGTGGATGAGGTCCACGGACTCAAGGGGACGCGCTTCAAGGCTGGCCGCTGA	MLQQDSNLTSSDGVDDIVIRDATEADRAVIQGLLHGSLRRNYDGDHVAQADRIIDAHLGGGKDPVGHFSKTQHVYVAESGGEVVGVMNIAEKRQGTMKISPLIVNPDFRGSKGAGSALLAKSVEVARARGVRQLYGTVAEPSSWIETFYLNRGWTCGSQSNSQYRPGVVEHAIYYNVDDTAATASEPLKFEEYSPSKYEELERFLTSRMDVFVDGIDEEFVRALVAGHERRGTREVEAKYKEIYLGYESGVLSSVIAFGPKKGGAVKLMPLSATSQDALRQTLRFAQSWAEGRTHKLYTHQHVDPAVVTAFQSEMWTLEGLLPEAYAADKVAAQWGWLPGETTHLGRNSDRLKAYTERFLTFVQDRGWDRIEEARSLAMAVGGEAGELLAELQWLSETEVVELLRMDREFKTRVSFEAADILNYLIRLARYCEFDLIEAADKKLAVNIDRFPVDEVHGLKGTRFKAGR	MEYSIINIVEQNNYQIDAARILTNTFLDIGNKTWPTIQSAIDEVEECIDLPNICIGLIHNNQLIGWVGLRPMYDKTWELHPLVVRTDYQSKGIGSVLLAEVEKRAREVGIIGIILGTDDEYNKTSLSEITIDENNIFDAIQNIKNIHNHPYEFYQKNGYMIVGIIPNANGLRKPDIWMWKSLLN	254.35	gnl|BL_ORD_ID|2023|hsp_num:0	2191			177	330	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000953.1|Amicetin_5 # 3707 # 5194 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.705	BGC0000953.1|Amicetin_5 	3707	5194	+	Loose	700	46.9802	LpsB	26.84	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGAACATTCTTTTCGTATGCAGCGTGTACTACCCGGTGACCGGTGGTGCGCAGGACCCCATCGACCAGCTCGGGGCCGAGCTCGTCGCACGCGGACACCACGTGGACGTGCTGACGCGCCACGTCCCCGACACCACACCGAAGGAAGAGATGCGGGGCGGGGTCCGTATCCACCGCGTCCCCAATGCGGTACTGCCTTCCGACTTCCAGGCGCTGACGGCCGAACTGCGCCAGTTCGTCCGCACCGTCCGCAGGCCCGACGTCATCCATGTCGTCGGCCTGCGCCGCCCGCTCCCGATGGTCGCGGAGCTTCTGGCCTGCCTGTGGCACGTGCCGGTCATCCAGACCGTGGGCGGCTACGACATCCCCGACGTGGTCGATCCTGACCCGCGCCTGGTGTGGCTGACCGGGCGGGATTTCGTCCTGCCGGCCATGCGACGCGCGGACCTGCTTAACGCGGCGTCGGACGACCTGGCCCGGCAGACGGAGCTGCTCGTCGGCGAGAAGGCCCCGGTGCCCACCCTGTACGTGGGGATCGACCACGATCTGTTCAGCGCCGCGCAACCCCACGGGAAGGCGGCCGACTGGGGGCCGTACGTGCTGTCGCTGCGCCGGCTGGAGCCCGCCAAGTCGGTGGACAAGACCGTCGAGGCGCTCAGTCTCCTGAAGGACGAGATCCCGGAGCTCCAGCTGGTCGTGGCCGGGGACGGCAGCGAACGCGCCGCCCTGGAGGAGTACGTCGAACGGCTCGGCCTCGGCTCTCGCGTCCACTTCGTCGGCGAGGTGCCGATCGAGGAGGCCGCCTCATTGCTGAAGGGCGCGTTCGCCACTGTCGTGGCCTCCAAGTCGGAGGGCGGCGGCCTCGTGAACGTCGAGGCCCAGGCCGCCGGTTGCCCGGTGATCGCCACGCGGGCCGGCGGCATCAGCGAGTACCTGGGGGGCGAGTCCGGAGCCCTGTACGTGGACGTCCCGGACGGCGTCCTGATCGCGGATGCGCTGCGGACCCTGTGGCACGACCCGCAGGCCAGGGAAGAGCTCGTTGCGGCCGCGCGCCCGCTCTCCGAACGGCTTTCGACCCGTTCGCTCGCCGAGGAGTACACGGCCGTCTACGCGGGTCTCGCCGAGGCTTACGAGGCGCGGGAGTTCGTCCCCTGGGACGGCATCACCTCCGCTCTGTGGGAGGAGCTCGCTGTGCCCGCGGGACGCAACCCCACCCTGGACGAACCCTGGCGGGTGCCGCTGGCGGTCGAGGAGCTCATCCTGTCGACGGCGGACCCGCAGTTCCGCGCACTCGGGCGCGGGGCGGACGCCTTCTTCTACCTGGCGTGGTCCAGCGGAGTGCCGGTCGAGCAGCTGCACAAGGTGTGCGCGTTCGTCCTGCAGGCCACCGAAGGGATGCCCGCGGACACCGTCGCCGCCGGCCTGGAGCACGCGGCTGACTGGGGGCGCTTCGACAGCGACAGCTGCCTCGGATACATCCGGAACTAG	MNILFVCSVYYPVTGGAQDPIDQLGAELVARGHHVDVLTRHVPDTTPKEEMRGGVRIHRVPNAVLPSDFQALTAELRQFVRTVRRPDVIHVVGLRRPLPMVAELLACLWHVPVIQTVGGYDIPDVVDPDPRLVWLTGRDFVLPAMRRADLLNAASDDLARQTELLVGEKAPVPTLYVGIDHDLFSAAQPHGKAADWGPYVLSLRRLEPAKSVDKTVEALSLLKDEIPELQLVVAGDGSERAALEEYVERLGLGSRVHFVGEVPIEEAASLLKGAFATVVASKSEGGGLVNVEAQAAGCPVIATRAGGISEYLGGESGALYVDVPDGVLIADALRTLWHDPQAREELVAAARPLSERLSTRSLAEEYTAVYAGLAEAYEAREFVPWDGITSALWEELAVPAGRNPTLDEPWRVPLAVEELILSTADPQFRALGRGADAFFYLAWSSGVPVEQLHKVCAFVLQATEGMPADTVAAGLEHAADWGRFDSDSCLGYIRN	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	135.25	gnl|BL_ORD_ID|2781|hsp_num:0	3793			165	936	colistin A; colistin B; defensin
BGC0000953.1|Amicetin_6 # 5202 # 5951 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5bp;gc_cont=0.691	BGC0000953.1|Amicetin_6 	5202	5951	+	Loose	300	28.1054	catV	37.21	3004357	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol acetyltransferase (CAT)	ATGCCGAAGGATTCCCCGCCACAGGCCACCTCGGTGACCTCGCGGCGGTTCTACGATGCCTATGCACGCGGCTACGCCGCGTACTTGGAGCGCCATGCCGGGTATTTCCGCGCCGTCGAGCAGGAGATAGCCTCGGCCGCCGCGAACCGGAAGGGTCTCGCGCTCCTCGACGTGGGCACCGGCACCGGCGAACGGCTGCGGCGGGTGGTCGCGGACATCCGCCCCGATCACGTCGCCGCCATCGACGAGAGTGCCGAGATGGCCGCCCTCGCCCAGAACAACTGTCCGGGTGCCCAGGTGCTCGCGACACCGCTCGGGGAGGCCGGACTGCCGGCCGCCCTGGCGGTGAGGTTCGACCTGGTGACGTGTCTGTCGAACGTCCTGGGCCATATCCCGCGTACGCAGCTCGTGCCGGGGCTACGGCAGATCAGGGACCTGCTGAGACCCGGTGGCGTGTTCGTCTTCGACGTTAACAACCGCTACAACGCGGTCGCGTACGGCGCGTTCAGCGCGACCCGCAACGTGGTGCGCGACTGGGTGCTGCCGGGCGGCGGGGACTTCACGGCGGCCTACCGGCACGGTGACGAGGTATTGCGCACCCCGGTCCATCTGTTCAGTCCGTCCGAAGTGGCCGGGCTCCTCCGGGAGTCCGGATTCAGGGCGGCGAGCCTCGGATTCCGGGATTACGTGACGGGCCGGGAACGAGGCCGATTCGGCGGGAGCATCGTAGTGAAGGCGGTCAGCGCATGA	MPKDSPPQATSVTSRRFYDAYARGYAAYLERHAGYFRAVEQEIASAAANRKGLALLDVGTGTGERLRRVVADIRPDHVAAIDESAEMAALAQNNCPGAQVLATPLGEAGLPAALAVRFDLVTCLSNVLGHIPRTQLVPGLRQIRDLLRPGGVFVFDVNNRYNAVAYGAFSATRNVVRDWVLPGGGDFTAAYRHGDEVLRTPVHLFSPSEVAGLLRESGFRAASLGFRDYVTGRERGRFGGSIVVKAVSA	MKFQRIDLDNWSRRSYFEHYLNRVNCTFSMTANIDITELLPALRQKEMKLYPAFLYMVTNAVNAHREFRTSFHADGELGYWESMIPSYTFFHQDDQTFSTMWTEFADEFPVFYQNYVADMKKYGDNKGLVAKELEPPYTFPVSCIPWVSFSGFNLNISGDGRYLLPIITSGKYFGQEGKTLLPVSLQVHHAVCDGYHASLFIHDLQKWATNYKEWLGVE	113.70	gnl|BL_ORD_ID|2481|hsp_num:0	2873			69	192	chloramphenicol
BGC0000953.1|Amicetin_7 # 5948 # 6496 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=10bp;gc_cont=0.690	BGC0000953.1|Amicetin_7 	5948	6496	+	Loose	575	26.1794	ELM-1	27.94	3006885	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	ELM beta-lactamase	ATGAAGGGTTCCCTCGTCGCCCACCCGAAGGTGTTCCTGGCGGCGCCGTTCGGCAACTACGTACACGACGACGTGTTCCTGCCGGAGAAGAAGGCGGAGATCCTCGCTTACCACACACGTCTGACTGAACTGGGCGCCGCGGTCTTCAGCTCCCACATGAACGAGGAGTGGGGTGCCGCGGGGCTGCCGCCCGAGGACTGCATGCGGGACGACCTGCGGGCCCTGCACGCCTCCGACAGCCTGTGCGCGCTCGTCGGCGACCAGCCCTCGGCGGGAGTGGCCTTCGAGCTCGGGTATGCGGCCGCCGTTCGGCGGCCCACCGTCCTCGTCACCTCGTCCTTCCACGCCCAGTCCTCCATGATCCGGGGCATGGGCACCCTGCTCGAACTGGAAGTCGTCGAGGGGGACCCGGGCAGCCGGGCGGTCGTCGAGAAGGCCTGCTCTGTGGCGCTCGAACTTGGCGCGACGTACCGGCAGGCGGACCGGTTCTGGGAGAGCACGGAGGTCGAGAGAGCCCTGAAGTTCCGCGCCGGGGGAGGGACGCGATGA	MKGSLVAHPKVFLAAPFGNYVHDDVFLPEKKAEILAYHTRLTELGAAVFSSHMNEEWGAAGLPPEDCMRDDLRALHASDSLCALVGDQPSAGVAFELGYAAAVRRPTVLVTSSFHAQSSMIRGMGTLLELEVVEGDPGSRAVVEKACSVALELGATYRQADRFWESTEVERALKFRAGGGTR	MPMEQALFVRIARALAASLITLSAVAFAQEPKVDIPADQQAFVDICKPWDEWDKPAPPFEIYRDTYYVGTCGIAAILITDEEGHILIDSGTEAGADVVMANVAALGFDLKDVRYLLYSHEHFDHVGGMAKLQRATGALVVASKAAEPVLTSGEDSLADPQHGMHEPFEGVAVGRIMAAGDILELGGTTIRAIETPGHTPGAMSWWWQECKERCENIVYADSLSPISRDDYRFGDHPEYVAAYRAGLVALGREDCTVLLTPHPSHSRMIRRMQEGDLIENRQGTRPCARYAGQKLLDLETRLSNETLSEEDRAQ	58.15	gnl|BL_ORD_ID|3530|hsp_num:0	4599			696	891	
BGC0000953.1|Amicetin_8 # 6493 # 7704 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.699	BGC0000953.1|Amicetin_8 	6493	7704	+	Loose	300	28.4906	tet(Q)	28.05	3000191	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGAGCGCGCCCGTTCCGACGCCGGGCGGTATTCGGATCGGCATTCTCGGCGTCAACTTCGGCTGGGGGCCGCACGCCGCCCTGGAGACCATCATCAGCGAGATCCGGCGGACGGCGCCGGGGTACTGCCGGGTCGTCGCCTTCGGGAGCGAGTACGGGCGCTCTCTCATGGACGACGTCGTCGACGAGTGGTGTGCCTTCGACGGTTCGGATTACGAGGCGCTGACGCGGGCCGCCGCGGCGCAGCACCTCGACGTGGCGCTGGTGACGCTGGAGGGCTTCGCCGCCCGCGCCTTCGAAGCGGCGGGCGTGCGCACCGTCTTCGTCGACCTAATGCCGTTCCTGTGGCACGGCGCGGACCTCGCCGTGCCACCGCTCGACGTGAGCCACTACCTCGCCTTGAGGCTCCCCGGACTGAACCAGGGCACCCTCGACTGGATGGGCGGCATCCGCAACCTGCGGTGGATCGGCGCGGTGGTCCCCTGGCAGCCCCTCGACACGACCCGGCACACCCACGGGTACGCCGAGGGGAACCGGCGGGCGATCGTCACCCTCGGCGGGATGCTCGGACTGACCACGCGGGACACTACGAGTTACCCGTCCCTGGTGCTCCCGGGCGCCGTCGAAGCTCTCCTAGAGACCGGATTCGAGAGCATCCTCATCGCCGCCAACACCCCCAGGGAGGACCTGGACGCCATAGTCGCCCCGTACCGCGAGCGCGCCGAATTCCGTTTCGGACCGCTGAGTCGCACCGAGTACCGCACGCGCATCGCGCAGAGCGCGCTGTGCCTCAGCCAGCCGGGCCTGATGAGCCTGCTGGAAGCGAGCTCCTGCGGGACACCGCTGATCCGCCTGCCACCGCAGAACGTCTCCGGATTCCAGCAGGCGGAGATCCACAGGATCGCGACCGGGGCCCACACCGGTGTCAGCTGGCCCACCGAGGTCGTCGACGAGGCGGTGGTCGCACAGAAGGCAGCACAGACCGAGGCCGCCGGGAACGATTACGTCTACGGGGCAATCGCGGAGGGCCTGTGCCGGCATCCCGACGCGACCCGTAGGTCGGTGAAGACGCAGCTGGAAAGGCTGATCCCGGAGTGCCTGGCGCTGCCCGCCGACGCCTGGACCGGTCTGGTGGACAAGGTGGGTACGGACGGTGCGAAGGTGACCGCGGAGGTCGTGCTCGACACGGCTCGCGCGGGCGTCGCGAACTGA	MSAPVPTPGGIRIGILGVNFGWGPHAALETIISEIRRTAPGYCRVVAFGSEYGRSLMDDVVDEWCAFDGSDYEALTRAAAAQHLDVALVTLEGFAARAFEAAGVRTVFVDLMPFLWHGADLAVPPLDVSHYLALRLPGLNQGTLDWMGGIRNLRWIGAVVPWQPLDTTRHTHGYAEGNRRAIVTLGGMLGLTTRDTTSYPSLVLPGAVEALLETGFESILIAANTPREDLDAIVAPYRERAEFRFGPLSRTEYRTRIAQSALCLSQPGLMSLLEASSCGTPLIRLPPQNVSGFQQAEIHRIATGAHTGVSWPTEVVDEAVVAQKAAQTEAAGNDYVYGAIAEGLCRHPDATRRSVKTQLERLIPECLALPADAWTGLVDKVGTDGAKVTAEVVLDTARAGVAN	MRFDNASIVVYYCLIQMNIINLGILAHIDAGKTSVTENLLFASGATEKCGRVDNGDTITDSMDIEKRRGITVRASTTSIIWNGVKCNIIDTPGHMDFIAEVERTFKMLDGAVLILSAKEGIQAQTKLLFNTLQKLQIPTIIFINKIDRDGVNLERLYLDIKTNLSQDVLFMQTVVDGLVYPICSQTYIKEEYKEFVCNHDDNILERYLADSEISPADYWNTIIDLVAKAKVYPVLHGSAMFNIGINELLDAISSFILPPESVSNRLSAYLYKIEHDPKGHKRSFLKIIDGSLRLRDIVRINDSEKFIKIKNLKTIYQGREINVDEVGANDIAIVEDMEDFRIGDYLGTKPCLIQGLSHQHPALKSSVRPDRSEERSKVISALNTLWIEDPSLSFSINSYSDELEISLYGLTQKEIIQTLLEERFSVKVHFDEIKTIYKERPVKKVNKIIQIEVPPNPYWATIGLTLEPLPLGTGLQIESDISYGYLNHSFQNAVFEGIRMSCQSGLHGWEVTDLKVTFTQAEYYSPVSTPADFRQLTPYVFRLALQQSGVDILEPMLYFELQIPQAASSKAITDLQKMMSEIEDISCNNEWCHIKGKVPLNTSKDYASEVSSYTKGLGVFMVKPCGYQITKGDYSDNIRMNEKDKLLFMFQKSMSSK	61.34	gnl|BL_ORD_ID|1219|hsp_num:0	1183			477	681	tetracycline; doxycycline; minocycline; chlortetracycline; demeclocycline; oxytetracycline
BGC0000953.1|Amicetin_9 # 7768 # 8667 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.732	BGC0000953.1|Amicetin_9 	7768	8667	+	Loose	500	26.1794	LpsA	27.87	3005052	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	GTGACCGCTGTGCTGGCCGCGGACGGATGGCACTGCACGGGCGTGGACCGGTACGGGCGCGCGACGGACGGAGCCGGGGACGTCGGCGGCTCCTACTACCGTGGGGACGACTGGTCGCCCGTGGCGCTGTCCCGGTACCTGCGGGACCGGGGCCCCGTCCTCGTCGTCAACGCCGTGGGCGCGCCCTGGTCCACCGACCCCTCGGTGGTGCGCCGGGACAACGCCGTGTGGCCGTGCCGCCTCGCGCAAGCGTGCGAACGGTCGGGGACTGTAACGGCGATCCTGCACCTCGGGTCGTCGCACGAATACGGTGACACCGCCCCCGGCGTCCCGGTCGCCGAGTCGAGTGCCTTGGCGCCCGTGACGGAGTACGGCAGGTTCAAGGCAATGGGCGCCTCCTATCTGGTGCGCGCGGCCTACCGGACCACTCGTCCGGTGACAGTGATCCGCGCCTTCAACGTGATCGGGCCGGGGCACGGCCGCAACGGCATCTGGGCCACCGCGGCCGGTCTCTACCGGGCCGCGGTGCAGGAGGGCCGCAGCCAGGTGGTGGCCAACGCCCCGCTGCCGGAGACGGCGCGGGACCTGATCGACGTACGGGATGTGGCGGCCCTGGTGAGCCTAGCCGCGCGGCGTCCGGGGCCGGCGGTGGCCGTCTACAACGCGGCGTCCGGGACCGCCACGAGCATCCGGCAGCTCTTCGACGCCTTCGCCGGGCACACCGGGATTCCCTATCGTTTCGCGCGCAATCCCACAGGCCTGCGCATCGGATCGACGTGGCAGTGCGCCGACACCACCCGTGCGCGCACCTACCTCGGCTGGACGAGGCGCTTCACCCTGACCGACTCCGTAGGCGCGGCCCTCGCTCTCGACGCGGCGGCGCCGGCCACGCTCGGCTGA	MTAVLAADGWHCTGVDRYGRATDGAGDVGGSYYRGDDWSPVALSRYLRDRGPVLVVNAVGAPWSTDPSVVRRDNAVWPCRLAQACERSGTVTAILHLGSSHEYGDTAPGVPVAESSALAPVTEYGRFKAMGASYLVRAAYRTTRPVTVIRAFNVIGPGHGRNGIWATAAGLYRAAVQEGRSQVVANAPLPETARDLIDVRDVAALVSLAARRPGPAVAVYNAASGTATSIRQLFDAFAGHTGIPYRFARNPTGLRIGSTWQCADTTRARTYLGWTRRFTLTDSVGAALALDAAAPATLG	MHNAAQHNYVISLTTEQKRRKHITEEFGKQNIPFEFFDAITPDIIEETAKKFNITLDRSPKAKLSDGEIGCALSHIVLWDLALENNLNYINIFEDDIHLGENAKELLEIDYISDDIHVLKLEANGKMFFKQPKSVKCDRNVYPMTVKQSGCAGYTVTAKGAKYLLELVKNKPLDVAVDSLVFEDFLHFKDYKIVQLSPGICVQDFVLHPDNPFESSLQEGRDRVHGNQRKFSILEKIKNEFGRVKIKMFGKQVPFK	116.80	gnl|BL_ORD_ID|2782|hsp_num:0	3794			291	474	polymyxin B; defensin
BGC0000953.1|Amicetin_10 # 8692 # 10206 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.682	BGC0000953.1|Amicetin_10 	8692	10206	+	Loose	1000	67.0106	almE	23.85	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGGAACCGGGGAGATTCATGAACAGCGACACTTCCATCCTGGCCGTGCGTCTCGCGGACGCAGGAGGTTGGACAGACCGGGCCGCCGTCGTCGACGAGCGGACGGGGGAGGTCCACCGGCACAGGGAGGTCCACGCCCGTGCCCGCGCCCTCGCCGAGGAATTTCTCCGCTGCGGGATCGGCGCGGGTGACCACGTCGGGTTCCTTGTGGGAGACCGGCCCGAGTGGATGCCAGCCTTCCTCGCCCTGCACGCCGTCGGGGCCGTACCCCTGATCGTCAATCCGGACCTAGACGTGCACGTGCAGGCGCGGATGCTGGACATACTGCCGACGCGGTACGTGATCTCCTACCGCGACGGCGCGCTGAGCGTCGAACGGCTCAGCCCGCGGCCCTCGGACAGCCCGGACGACCACGTGCAGGAGGCGGCGGCCTCGCGCTATTACCTCTACAGTTCGGGCACTACCGGAATTCCGAAGGCCGTTGCCCACACAAGTGCCGACCTGCCCTTCTTCCACGAAGCGGTCGGCGGTCCGAACGGCCTGGACATCACGGCGGACGACACCATCGTCTCGCTGTCCCAATATTATTTCACCTACGGATTCAACAATCAGTTCGTCTATCCGCTCTTCAGCGGTGCAGCGGTCGTGCTGAGCCCGCAGCGCAGGAACGAAGAAGGATTCGTCGATTCCCTGCACCGGCACGGTGGCACCCTGGCTTTCTCCGTCCCGTCCGCGCTGGCCAGGCTCGCCGATCACGTCGAGAGCGCGGCTGTCGAACGCCCGGTGGCGCTGCGGGCGATCGTCTCCGCGGGCGAACCCCTCCCGGAGACCGTCGCCGCACGCCTGGAAGAGCGCTGGCAGGTACCGGTGCTCAACCAGATCGGCTCCACGGAAGTGGGCAACGCCTTCTGCGTGAACGGCGTAACGCACCGCGCGGCCGGCACGGCCGGCTTCGTCTGCCCCGGCTACGAGGTGGAGCTGCGCGGCGACCCGGGCCTGCCCTCGCCGACGGTCGGGCCGCAACACAAGGTGGGCGCAGTGTGGGTGTCGGGCCCGACCGTCGCGCGTCGTGCGGTCACCGCCGACGGCACGCGGGAGTTGCTGGTCGACGGCTGGCTGGAGACCAAGGACTACGGCTACTGGGCCGACAACGGCGGACTCGTGGTCGTCGGCCGCACCGACGATTTCCTGCACGTCGGCGGGATCTCCATGTCGGCGGTGGAGATCGAGGCGGTCCTCAGGAGCTGTGCGGACGTCGAGGACTGCGCCGTACTCGCCCCCCTGGTCGAGGGCGTGTCCACCCTGTCCGCGCTCGTGGTGCTCGCCCCTTCTGCCGGGGACCAGGACGCGTGTTTCGCCGCGCTCCGGACGCACCTGCGCCGACACCTTGAACCTTTTCGCATCCCGAAGCGGTGGACGCTGGTGGCGGAGATTCCCCGCACCGGCAGCGGCAAGATCATGAGGCACAAGCTAAGCTCCGTACTCGGCGGCGGAAAACCTGGAATGGTTCGATGA	MEPGRFMNSDTSILAVRLADAGGWTDRAAVVDERTGEVHRHREVHARARALAEEFLRCGIGAGDHVGFLVGDRPEWMPAFLALHAVGAVPLIVNPDLDVHVQARMLDILPTRYVISYRDGALSVERLSPRPSDSPDDHVQEAAASRYYLYSSGTTGIPKAVAHTSADLPFFHEAVGGPNGLDITADDTIVSLSQYYFTYGFNNQFVYPLFSGAAVVLSPQRRNEEGFVDSLHRHGGTLAFSVPSALARLADHVESAAVERPVALRAIVSAGEPLPETVAARLEERWQVPVLNQIGSTEVGNAFCVNGVTHRAAGTAGFVCPGYEVELRGDPGLPSPTVGPQHKVGAVWVSGPTVARRAVTADGTRELLVDGWLETKDYGYWADNGGLVVVGRTDDFLHVGGISMSAVEIEAVLRSCADVEDCAVLAPLVEGVSTLSALVVLAPSAGDQDACFAALRTHLRRHLEPFRIPKRWTLVAEIPRTGSGKIMRHKLSSVLGGGKPGMVR	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	90.65	gnl|BL_ORD_ID|4935|hsp_num:0	5928			564	1611	colistin A; colistin B
BGC0000953.1|Amicetin_11 # 10203 # 12236 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.680	BGC0000953.1|Amicetin_11 	10203	12236	+	Loose	450	28.1054	KBL-1	42.86	3007206	protein homolog model	n/a	n/a	penam	antibiotic inactivation	KBL beta-lactamase	ATGACTCGTATCCTTCTCGTCGACAACTACGATTCCTTCACCTACAACATCTGGATGTATCTGAGCGAGCTTCCGGATGTCGAATGCATCGTCGTCAAGAATGACGACCCGCTGACGTCGATATCCCTGGAGGAATTCGACGGCATAGTGATATCCCCGGGCCCGGGGAGTCCCGAGGTACCCGCCGACGTGGGGATCTCCCGCACGCTCGTGACGTCGGCGGACCTGCCCATCCTCGGAGTCTGCCTCGGACACCAGCTCATCGGCAGCGTCCACGGGGCGAAGGTCGGGCCGGCTCCGAGGATTATGCACGGGCGGGCGTCCCGGGTCCGGCACGGAGGGGACCGCCTCTTCCGAGGCATGGCCGAGGAGTTCACCGCCGTCCGCTACCACTCGTTGGCCCTGTCGGGCGTCGAGGCGCCGCTCGAGGTCATCGCGGAGGACGAGGACGGGGTCGCCATGGCGATCCGACACCGCGAGCGCCTGCTGTGGGGCGTCCAGTTCCACCCGGAGTCGATTCTCAGTGACGACGGAAGGGTGCTGCTGAGGAACTTCGCCGAGATCGTGGCGGATCACAGGTCCGAGGCGCCCCGCCAGGCAGTCCCGGTCGGTGGGGTCGACTGCATATGGGTGTGCGTGGAGGGAGAGGCCGACGGCCGGGCCCTGCACGAGGCGTTCTGCGGCACATCGACGGAGAGCTTCTGGCTCGACAGCTCGGACACCGGCCAGGCGCGCTTCTCCATCATGGGCGGGCTGCCCGACGCCCGCACCACCACGGTGAGTTACCGCGTGCGCGACGGCCGCACCACAGTTACGGAGCCCGACGGTTCGGTGCGGCACGTCGACGCCGACATCTTCACCTTCCTCAAGGACCAGCAGCGCGTCGTCAACGTGTACAGAGAGGAACTGCTGCCCTTCGAGTTCCGTCCCGGATTCGTGGGCTACTTCGGGTACGAGCTGCGGGCCGACACCGCGCGGATGGAGGTGAACCGGCACGCGCGGCTGCCCGATGCCCGCTTCCTGCTCACCGACCGCTATGTGGTCGTCGATCACCAGGAGAACCGGGTCTACCTGCTGTTCGCGTCCGGGCCCGGGCTCGGTGAACCAGCCGACGCGCTGACATGGTTCGCGAGCGCGACCCACACGGTCGAACGGGCGATGGCGGCGCCTTCGCGCGGCGGGGAGCGGCTGCCCGCGGCGAGGCCAGCAGAGGTCGCCTTCCGGGACGGCAAGGAGGCGTACCTGGCGAAGATCCTGAAGTGCCAGGACTATCTGAGCAGCGGTGACTCGTACGAGCTCTGCCTCACCAACACCGCTTCGATCAGCGGTGAGTTCGACGCGGCGGCGACGTACAGCCGCCTCCGCGCCGCCAGCCCGGTCCCCTACGGAGCGTTCCTGCGGACGCCGGAGTTCAGCGTACTGTCTGCCTCGCCCGAGAGGTTCATGACCATAAGCGGAGACCGCACCGTGCGAGTTAGCCCCATCAAGGGAACGCGCAGGCGCGGCGCCACCGCGGACGAGGACGAGGCACTGAAGCGGGAGCTCGCGGGCGACGAGAAGGAGATCGCCGAGAACCTCATGATCGTCGACCTGATGCGGAACGACCTCAGCCGGGTCTCTGAGATCGGGTCCGTGCGCCCCGTTGAGCTATTCGCAGTCCACACCTTCGCGTCGGTGCACCAGCTGGTGAGCACCGTCGAGTCGAGGCTGCGGCAGGACGTCGCGGCGGTGGACTGCATCCGCGGTGCGTTCCCGCCCGGCTCGATGACCGGCGCGCCGAAGCTGCGGAGCATGGAGATCCTGGCCGCGCTGGAGCAGGAACCGCGGGGTGTCTACTCGGGAGTGCTCGGGTGGGTGTCCCTCGACGGTCGCGCCGATCTGAGCGTGGTGATCAGGACCCTCGTCCTAGAGGAGGGGCGCGCGTCGTTCGGGGTCGGAGGCGCCATCACGCTCCTGTCGGACCCGGAAGCGGAGTACGCGGAGACGCTGGTGAAGGCGGCCGCCCCGAAGTCCGCCTTCGGCGGCCCCGCGTGA	MTRILLVDNYDSFTYNIWMYLSELPDVECIVVKNDDPLTSISLEEFDGIVISPGPGSPEVPADVGISRTLVTSADLPILGVCLGHQLIGSVHGAKVGPAPRIMHGRASRVRHGGDRLFRGMAEEFTAVRYHSLALSGVEAPLEVIAEDEDGVAMAIRHRERLLWGVQFHPESILSDDGRVLLRNFAEIVADHRSEAPRQAVPVGGVDCIWVCVEGEADGRALHEAFCGTSTESFWLDSSDTGQARFSIMGGLPDARTTTVSYRVRDGRTTVTEPDGSVRHVDADIFTFLKDQQRVVNVYREELLPFEFRPGFVGYFGYELRADTARMEVNRHARLPDARFLLTDRYVVVDHQENRVYLLFASGPGLGEPADALTWFASATHTVERAMAAPSRGGERLPAARPAEVAFRDGKEAYLAKILKCQDYLSSGDSYELCLTNTASISGEFDAAATYSRLRAASPVPYGAFLRTPEFSVLSASPERFMTISGDRTVRVSPIKGTRRRGATADEDEALKRELAGDEKEIAENLMIVDLMRNDLSRVSEIGSVRPVELFAVHTFASVHQLVSTVESRLRQDVAAVDCIRGAFPPGSMTGAPKLRSMEILAALEQEPRGVYSGVLGWVSLDGRADLSVVIRTLVLEEGRASFGVGGAITLLSDPEAEYAETLVKAAAPKSAFGGPA	MRLTFPFAAAVSILFALPLHAETVAEAARALEAELGGRIGVVLRAPEDDPLAVWRGDEAFPMASTFKVPLCGAVLARIDAGEEQAARILPVETAALVEWSPVTEQQAGRGMSIADLCHATITMSDNTAANLLLDTVGGPAGLTAFLRDIGDATTRLDRTEPALNEALPEDMRDTTTPAAMADTLELLLFSELLSPEARAQLESWMRQDAVADDLLRASLPEGWMIGDKTGAGGNGSRSIIAVLRGPAGEPWLATVYMTQTGGDMDKRNAAIARIGAAMIGEIQARR	236.71	gnl|BL_ORD_ID|4832|hsp_num:0	5818			594	678	amoxicillin; piperacillin; benzylpenicillin; ampicillin
BGC0000953.1|Amicetin_12 # 12281 # 13600 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=6bp;gc_cont=0.680	BGC0000953.1|Amicetin_12 	12281	13600	+	Loose	1000	27.335	efpA	26.03	3003955	protein homolog model	n/a	n/a	rifamycin antibiotic; isoniazid-like antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCCGCTGGCAGCGACAAAGACCAAATCCTCGAGCTCACTCGCAAATACCATCGAACCGGCGAGGCGGGGGACTTCGTGCCCGGCGTCACGCCCATCTGGCCCTCCGGCGCGGCCCTAGACGAGGACGACCGGGTCGCCCTGGTGGCCGCCGCCCTCGACCTGCGCATCGCCGCCGGCGTCAGCGCGCGGAAGTTCGAGCGGGGCCTGGCGCAGTACTTCGGTCTGCGGAAGGCCCATCTGACGAACTCCGGGTCGTCCGCCAATCTCCTGGCCGTCTCGGCGCTCTCCTCCCGGCAGCTGGGCGAGCGGCGGCTTCGCCCGGGGGACGAGGTCATCACAGTCGCCGCGGGCTTCCCGACCACGGTGAACCCCCTCGTCCAGAACGGCCTGGTGCCCGTGTTCGTCGACGTCGAGCTCGGTACGTACAACACCACCGTCGAACGGGTGGCGGCGGCAGTGACGCCGCGCACCCGGGCGATCGCCATGGCCCACACGCTGGGAAACCCCTACCAGGTCGCCGAGATCGCCGCGCTCGCCGAGGAGCACGGCCTCTATCTGATCGAGGACAACTGCGACGCCGTCGGCTCGACGTACCAGGGTCGGCTCACGGGCACCTTCGGCCACTTCGCCACCGTCAGCTTCTACCCGGCCCACCACATCACCACGGGTGAGGGCGGCTGCGTCCTCACCAATGATCTGAAACTGGCCCGGCTAGTGGAGCAGTTGCGCGACTGGGGCCGGGACTGCTGGTGCGAGCCCGGTCAGGACAACACCTGCTTCAAGCGATTCGACTACCAGCTCGGCACGCTCCCGCACGGCTACGACCACAAGTACATCTTCTCCGAGATCGGCTACAACCTGAAGGCGACCGATCTGCAGGCGGCGCTCGGCCTCAGTCAGCTCGGCAAGCTGGCGGACTTCGGAGAGAAACGGCGGCGTAACTGGAGCCGCCTGCGTGCGGCGCTGGACGGCCTGCCCGGCCTCCTGCTGCCCGAGGCCACCCCGGGGAGCGATCCCAGCTGGTTCGGGTTCGTACTGACGGTGCTGCCCTACGCGCCTTTCACCAGGCAGGAGTTGGTGGCCTTCCTGGAGCAGCGGCGCATCGGGACCCGGCGGCTGTTCGGCGGCAACCTCACCCGGCATCCCGCGTACATCGGACGTGACTACCGGGTTTCCGGTGAGCTGACCAACACCGACGTCATCACCGAGCACACGTTCTGGGTGGGGGTCTACCCAGGCCTGAGCATCGAGATGATCGATTACGTGGCGGAGAGCGTGACCGAGTTCGTGCATAACCGCGCCCGGAGGGCCGATTGA	MSAGSDKDQILELTRKYHRTGEAGDFVPGVTPIWPSGAALDEDDRVALVAAALDLRIAAGVSARKFERGLAQYFGLRKAHLTNSGSSANLLAVSALSSRQLGERRLRPGDEVITVAAGFPTTVNPLVQNGLVPVFVDVELGTYNTTVERVAAAVTPRTRAIAMAHTLGNPYQVAEIAALAEEHGLYLIEDNCDAVGSTYQGRLTGTFGHFATVSFYPAHHITTGEGGCVLTNDLKLARLVEQLRDWGRDCWCEPGQDNTCFKRFDYQLGTLPHGYDHKYIFSEIGYNLKATDLQAALGLSQLGKLADFGEKRRRNWSRLRAALDGLPGLLLPEATPGSDPSWFGFVLTVLPYAPFTRQELVAFLEQRRIGTRRLFGGNLTRHPAYIGRDYRVSGELTNTDVITEHTFWVGVYPGLSIEMIDYVAESVTEFVHNRARRAD	MTALNDTERAVRNWTAGRPHRPAPMRPPRSEETASERPSRYYPTWLPSRSFIAAVIAIGGMQLLATMDSTVAIVALPKIQNELSLSDAGRSWVITAYVLTFGGLMLLGGRLGDTIGRKRTFIVGVALFTISSVLCAVAWDEATLVIARLSQGVGSAIASPTGLALVATTFPKGPARNAATAVFAAMTAIGSVMGLVVGGALTEVSWRWAFLVNVPIGLVMIYLARTALRETNKERMKLDATGAILATLACTAAVFAFSIGPEKGWMSGITIGSGLVALAAAVAFVIVERTAENPVVPFHLFRDRNRLVTFSAILLAGGVMFSLTVCIGLYVQDILGYSALRAGVGFIPFVIAMGIGLGVSSQLVSRFSPRVLTIGGGYLLFGAMLYGSFFMHRGVPYFPNLVMPIVVGGIGIGMAVVPLTLSAIAGVGFDQIGPVSAIALMLQSLGGPLVLAVIQAVITSRTLYLGGTTGPVKFMNDVQLAALDHAYTYGLLWVAGAAIIVGGMALFIGYTPQQVAHAQEVKEAIDAGEL	82.83	gnl|BL_ORD_ID|2188|hsp_num:0	2427			1191	1395	rifampin; isoniazid
BGC0000953.1|Amicetin_13 # 13693 # 15321 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=7bp;gc_cont=0.697	BGC0000953.1|Amicetin_13 	13693	15321	+	Loose	1300	163.696	optrA	26.15	3003746	protein homolog model	n/a	n/a	oxazolidinone antibiotic; phenicol antibiotic	antibiotic target protection	Miscellaneous ABC-F subfamily ATP-binding cassette ribosomal protection proteins	GTGTTGTTGGACGGGATCTCGTTCCGGGTCGGCGAGGGGGCGAAAACCGCGCTGATCGGCGCCAACGGATCCGGGAAGACAACGTTGTTCCGCATGATCGCGGGGGACCTGGCGCCCCATGGCGGAGCGGTGAGCCGGAGTGGAAGCCTCGGCGTCATGCGGCAGTTCGTCGCCCGCCAGGGTGACCAGGTGCGGGATCTGCTCTTATCGGTGGCGGACCCTCGCGTCCGTCGGGCAGCGGCGACCGTGGACAAGGCGGAAACGGCCATGGAGGCGAGCGGGGATACCGCGGCGCAGATGGCCTACGCGGACGCGCTGGCCGAATGGGGCGACGCGGGCGGTTACGACGCCGAGGTGCTGTGGGACGTGTGCACCACCCAGGCCCTCGGCATGCCCTTCGAGCAGTGCCGGCGGCGCGCCGTGGACTCGCTGTCGGGCGGCGAGCAGAAGCGGCTCGTGCTCGAAGCGCTGCTGCGCGGCCCCGACCAGGTGCTGCTACTCGACGAGCCGGACAACTTCCTCGACGTACCCGGCAAGCGGTGGCTCGAGAACCGCCTGATCGAAACCCCGAAGACGGTCCTGTACATCAGTCACGACCGCGAGCTGCTCGCCCGTACCGCGCAGCGCATCGTCACGATCGAGCTCGGTGCGGCGGGCAACACCGCATGGGAACATCCTGGTGGCTTCGACACCTATCACCAGGCCCGGGGCGAACGCTTCGAGCGTTTCGACGAGTTGCGCAACCGCTGGGACGAGGAGCGCGCCAAGCTGAAGGCCCTCGTCCAGATGTACAAGCAAAAGGCCTCCTACAACTCGGACATGGCGTCGCGCTACCGCGCCGCCCAGACACGCCTCGACCGGTTCGAGAAGGCCGGGCCGCCTCCCGCGCAACCGCGCGAACAGCACCTGTCGATGCGGCTGCGCGGCGGGCGAACCGGCAAGCGGGCCGTGGTCTGCGAAAACCTTGAACTCACTGGCCTGATGAAGCCATTCGACCTGGAAGTCTGGTTCGAGGACCGGGTCGTCGTGCTCGGTTCCAACGGCTCGGGCAAGTCGCACTTCCTGCGGCTGCTCGCCGCGGGCGGCAGCGCTCCTGAGCCCGAGCACGAGCCGGTGGGCGACCTTCCGGTCGAGCCCGTGACGCACGCGGGGGTGGCACGCCTGGGTGCGCGGGTGCGACCGGGCTGGTTCGCGCAGGTCCACGGGCGGCCTGACCTGGCCGGCCGCACGCTGGTGTCGATCCTCCACCGTGGCGACGAGCGCCGGGAAGGGCTGCCGCGCGAGGAGGCATCGCGGGCTCTGGCCCGGTACGAGCTGGCGGGCGCGGCCGAGCAGACCTTCGACTCCCTGTCCGGGGGGCAACAGGCGCGGTTCCAGATCCTCCTGCTCGAACTCGGCGGCACGACCCTGCTGTTGCTGGACGAACCCACCGACAACCTCGACCTCGTCTCCGCAGAAGCGCTGCAGCACGCGCTCCGTGGATTCGAGGGCACCGTACTCGCGGTCACTCACGACCGGTGGTTCGCCCGGGACTTCGACCGGTTCCTGGTCTTCGGTTCCGACGGCACCGTGTACGAGTCGCCCGAGCCGGTGTGGGACGAGAAGCGCGTAGTGCGCCGCCGCGGGTGA	MLLDGISFRVGEGAKTALIGANGSGKTTLFRMIAGDLAPHGGAVSRSGSLGVMRQFVARQGDQVRDLLLSVADPRVRRAAATVDKAETAMEASGDTAAQMAYADALAEWGDAGGYDAEVLWDVCTTQALGMPFEQCRRRAVDSLSGGEQKRLVLEALLRGPDQVLLLDEPDNFLDVPGKRWLENRLIETPKTVLYISHDRELLARTAQRIVTIELGAAGNTAWEHPGGFDTYHQARGERFERFDELRNRWDEERAKLKALVQMYKQKASYNSDMASRYRAAQTRLDRFEKAGPPPAQPREQHLSMRLRGGRTGKRAVVCENLELTGLMKPFDLEVWFEDRVVVLGSNGSGKSHFLRLLAAGGSAPEPEHEPVGDLPVEPVTHAGVARLGARVRPGWFAQVHGRPDLAGRTLVSILHRGDERREGLPREEASRALARYELAGAAEQTFDSLSGGQQARFQILLLELGGTTLLLLDEPTDNLDLVSAEALQHALRGFEGTVLAVTHDRWFARDFDRFLVFGSDGTVYESPEPVWDEKRVVRRRG	MSKATFAIASTNAKEDMKMQYKIINGAVYYDGNMVLENIGIEINDNEKIAIVGRNGCGKTTLLKAIIGEIELEEGTGESEFQVIKTGNPYISYLRQMPFEDESISMVDEVRTVFKTLIDMENKMKQLIDKMENQYDDKIINEYSDISERYMALGGLTYQKEYETMIRSMGFTEADYKKPISEFSGGQRTKIAFIKILLTKPDILLLDEPTNHLDIETIQWLESYLRSYKSTLVIISHDRMFLNRIVDKVYEIEWGETKCYKGNYSAFEEQKRENHIKQQKDYDLQQIEIERITRLIERFRYKPTKAKMVQSKIKLLQRMQILNAPDQYDTKTYMSKFQPRISSSRQVLSASELVIGYDTPLAKVNFNLERGQKLGIVGSNGIGKSTLLKTLMGGVAALSGDFKFGYNVEISYFDQQLAQISGDDTLFEIFQSEYPELNDTEVRTALGSFQFSGDDVFRPVSSLSGGEKVRLTLCKLLYKRTNVLILDEPTNHMDIIGKENLENILCSYQGTIIFVSHDRYFTNKIADRLLVFDKDGVEFVQSTYGEYEKKRMNSEKPFNNIKVEQKVEKNNTVKGDRNSIEKEKVKKEKRIEKLEVLINQYDEELERLNKIISEPNNSSDYIVLTEIQKSIDDVKRCQGNYFNEWEQLMRELEVM	82.75	gnl|BL_ORD_ID|2069|hsp_num:0	2263			99	1656	linezolid; chloramphenicol; florfenicol; tedizolid
BGC0000953.1|Amicetin_14 # 15839 # 16306 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.716	BGC0000953.1|Amicetin_14 	15839	16306	+	Loose	1050	26.1794	facT	44.44	3001313	protein homolog model	n/a	n/a	elfamycin antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGCGGCCGTGACCGAGGTCGGTAATCGCATGGGGAAGAGGCTCACCCGGTATCCCATCGACGCCCTGGCCGGACTCACGGGTGAACCCGCCGTCGACGCCCTGCAGGCACGCCTCGAGGAACTGCTGCCCATCGACGAGGAGCGCCGAGTCGAGTCGATCGTGCTGACGGAATTCATCGTCGCCGCCCGGGTGAACCCGACTTTCCGCCCGGTGACCGAGCAGATGGCCGCCGACATGCGCCAGGTCATCACGGACGCCCTGCGCGTCCTCCACGTGCACGACCCTGCCGAGGAGGCCGAACGGCTCATCGCGGTCCTGGGTGGCCTGGTGCTGGACACGGTGACGCCGCACGGGTCGCTCGGTGTCGAGCGCCTGCGCGCGACGCTGCGGGCGCACCTGCGCATGATCCTCGCGGCCGGTGCCGGTGCCGGTGCCGGTGCCGGTGCCGCGTCGGCCGACGCCTGA	MAAVTEVGNRMGKRLTRYPIDALAGLTGEPAVDALQARLEELLPIDEERRVESIVLTEFIVAARVNPTFRPVTEQMAADMRQVITDALRVLHVHDPAEEAERLIAVLGGLVLDTVTPHGSLGVERLRATLRAHLRMILAAGAGAGAGAGAASADA	MNKAGQAEKPAAAGPPATPETPEPDPKRWLALTVLLVATFMDLLDANIITVAIPSIQRDLGASTFAIQAMTAGYTLSFAVLLITGGRLGDIFGRKRMFLVGVGGFVLASAMCAAAPSTDLLVVARALQGLTAAVMVPQVLALIHVSFAPQEIGRVVSLYASMVGLAIVSGPLIGGALISWNPLDLGWRSIFVVNLPVGVLALVGAAKWMRESSSPHAKRLDIAGMLLIVLGLLLLMVPLTLGRELDWPVWSIVSLVAAAPVLVLFVVYERHKTAKDGSPLVTLSLFKVRAFGAGIGVQLLFSAIPAGFFLSWTLYLQAGLGWSALHTGLTAIPFSLCVPIVGGLAVRRLSPLYGRYCLLAGAVLMLAGILSYAWAADRFGTDITSWHAIPSMLLIGSGMGMLMPPLTALVLREVQPQEAGAASGIINATGQLGAALGVAVIGSLFFAALAGNAGPQAERVAPTVQSVSPRQASDLRDCATEALGQDDLAKVPDICSTLVQGADDGTRDTINGALGEIRAKTFVSTYSETLYWAAGGLVPVTALVLLLPHHRVRREEPAQ	27.73	gnl|BL_ORD_ID|1345|hsp_num:0	1469			1368	1449	factumycin
BGC0000953.1|Amicetin_15 # 16356 # 17549 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=8bp;gc_cont=0.707	BGC0000953.1|Amicetin_15 	16356	17549	+	Loose	500	107.457	cmrA	30.79	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGCCCGCGTGGCTGTTTGCGCTGCTCGCTGCGGCTTTTGTCCTGTATACCGACGATTATGTGATCGCCGGGGTTCTGCCGGAGATCGCGCGAGACCTGGACGTCACGGAAGCGCACGCCGGTCAGCTCGTGACCGTCTTCTCGCTCACCGTTGCCCTGGCCGCGCCGATCGCCGGGGTAGCCCTCGCGCGGGTGTCCCGGCGGTACCTCTTCACCGCCGCGTTCGTGGTCTTCATCGCGGCCAACCTCGTGGCGGCCACGACGAACAGCTTCGGACTGCTGGTCATGCTGCGGATCGTGGCGGCGCTCGCCGCGGCGGCCTCGACCCCGGCGGTGTTCGCCTTCGCCGCCGAACGCGCCCCGCAGGGCCACATCGGACGCTACGTCGCCGTCGTGGCCCTGGGCGTCACGGGCTCGATCGCGGCCGGCGTCCCGGTTGGCACCTGGCTCGGCGGCCACCACGGCTGGCGGGCGACCTTCGTCGCCATGGCGGTGGGCGGCATCGCAGCCCTGGTGTTCCTGCTCGTGACGCTGCCCCGCGAGGGCGACAACACAGGTGAAGTGCCCAGTGTCCGCGAGCAGTTGCGCACCCTCACCAGCGCGCCGGTGTCGCTGGGACTGCTCGCCAACTGTGCCCTCATGACCGGCTCGATGATGATGCTCACGTACATGGCGCCCTACCTCGCAGAGGTGAGCGAGGCCAGCGTGGACCAGCGTGCGCTCGCCTTCAGCCTGTCGGGGTTCGCCGGCATCCTGTGTATCTGGGCCGGCGGGAAGGCCACCGACCGGTGGGGGCCGGACCGCGCCCTGGTCACCGGCATCGGCATCTTCACCGGAATCATGGCGGTGATGGGGCTGCTCTGGTTCGTCCGCCCGGTGCCCTTCTCCGTACTCGTTGTGATGGGCACGATCTGGGGCGGCATGGCCTTCTGGAACTCTCCGGCCATTCAGGCCCGCCTCTATCTGCTCGCCGGCCCGGTCGCCGCCCAGGCCTTGGCGCTCAACACGTCGAGCACGTACCTCGGGGTGTCCCTGGGCGGAGCCGTCGGCGGCCTGACGCTGGGCAGTGCCGGAGCCGGACTGCTCCCCGCCGTCGCGGCCGTACTCGGCCTGAGCGCCTTGGGGTTGCTGGCACTCGCCATCGGCGCCTCGAGGAAGTCGCCGACCGGTGCGGACGCGCTCGCGCCGCACTGA	MPAWLFALLAAAFVLYTDDYVIAGVLPEIARDLDVTEAHAGQLVTVFSLTVALAAPIAGVALARVSRRYLFTAAFVVFIAANLVAATTNSFGLLVMLRIVAALAAAASTPAVFAFAAERAPQGHIGRYVAVVALGVTGSIAAGVPVGTWLGGHHGWRATFVAMAVGGIAALVFLLVTLPREGDNTGEVPSVREQLRTLTSAPVSLGLLANCALMTGSMMMLTYMAPYLAEVSEASVDQRALAFSLSGFAGILCIWAGGKATDRWGPDRALVTGIGIFTGIMAVMGLLWFVRPVPFSVLVVMGTIWGGMAFWNSPAIQARLYLLAGPVAAQALALNTSSTYLGVSLGGAVGGLTLGSAGAGLLPAVAAVLGLSALGLLALAIGASRKSPTGADALAPH	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	101.53	gnl|BL_ORD_ID|1599|hsp_num:0	1744			0	1071	chloramphenicol
BGC0000953.1|Amicetin_16 # 17607 # 18506 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=10bp;gc_cont=0.682	BGC0000953.1|Amicetin_16 	17607	18506	+	Loose	500	26.9498	FAR-1	34.21	3004784	protein homolog model	n/a	n/a	penam	antibiotic inactivation	FAR beta-lactamase	ATGACGAAGTGCGTGGTGTTCGGACCGGCCGACGCCGCAGTGGATTTCCGCGGCTACGAAACGATGCTGCGCAACTCGCCGGTCGCGCGGTCGGTTTACCACGAGTTCGCCGATGCCCTGGACATTGCGGTGGACCACCTGTTCGACGGGGAGGTGCCGCGCGTTCATCCGGTACTGCTGCGCTGGATACGGCAGTTGGCCGCCATGGTCGCCGAGGGGCGGATCATCGAGCAACGGTACGGTATGGCCTCGGTGTACGGAGGTATCTCGTTGGGCGAGCTGGCTGCGCTGCACGCGGCGGGGGCGGCCTCGACGCACATGGTCGTCGACTTCCTCCGGGAGCGGCACCTGCAGGACACCGAAGGGGACGAGGCCATAGGGTTCGCGTTCGTGCCGACGCCGGTCGACTGGCGTTACTACGAGCAGCCGGAGCACATGACCATCTCCTGCGACTTTGGCCCGGTCCTCGGGGGCGCCGGTCGCATGATCATGGTGTCGGGGATGCGTTCCGCGCTGGTGGCGGCACGGCGCGAGGGCCCCGCCGACCTGCAGGTGGTGGAGCGGGCCCTGGCGCACCAGGCGTATCATTCACCGTTCCGTGAGCCCGGCAGGCAGCGGCTCGAGGCGCTGCTGAGGGAGAGCTCGCCCGACCGCCCCCGGGTCCCGGTGGTCACCGCGGTCCCGGGCATGCACATCGTGTCCTCCGGTGCGGAGGCCGCGAAGGCGCTCGTCGCGAGCGAGACCCAGTGCCTCGACGTTCCCGGCCTGGTGGCGGCCCTGCGGCAGTTCACGCCCGACACCGTGTACGTGATCAGTTCCTTCCTGCGCCAATTGGAGATCGAGTTCCATGCGGCGACCGAGTATGTCGACGATGCCTGGCTGAAGCAGAACTTCGGCTAG	MTKCVVFGPADAAVDFRGYETMLRNSPVARSVYHEFADALDIAVDHLFDGEVPRVHPVLLRWIRQLAAMVAEGRIIEQRYGMASVYGGISLGELAALHAAGAASTHMVVDFLRERHLQDTEGDEAIGFAFVPTPVDWRYYEQPEHMTISCDFGPVLGGAGRMIMVSGMRSALVAARREGPADLQVVERALAHQAYHSPFREPGRQRLEALLRESSPDRPRVPVVTAVPGMHIVSSGAEAAKALVASETQCLDVPGLVAALRQFTPDTVYVISSFLRQLEIEFHAATEYVDDAWLKQNFG	MAAAAAIALLGGCGADAGSEPATTAASTTAPSTATDAATAEFAALEQRSGARLGVYAVDTTSGAEVAYRADERFGMASTFKGLACGALLREHPLSSGYFDQVVRYSREEVVSYSPVTETRVDTGMTVAELCHATITVSDNTAGNQILKLLGGPAGFTAFLRSLGDEVSRLDRWETELNEVPPGEERDTTTPAAVAANYRALVLGDVLAEPERAQLRDWLVANTTGDQRIRAGVPAGWTVGDKTGGGSHGGNNDVAVAWTETGDPIVIALLSHRTDPAAKADNALLAEATRAVVTALR	100.67	gnl|BL_ORD_ID|2096|hsp_num:0	3583			210	324	
BGC0000953.1|Amicetin_18 # 20001 # 22466 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.695	BGC0000953.1|Amicetin_18 	20001	22466	+	Loose	1000	130.954	almE	29.73	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	ATGAATTCAGCCGACTCCACCACGCAGACGGCATCGACGCAGGCAGCATCGACCCAGACGGCTCACGCCTCCTTTCCCCCGGGGCCGGGACACCGCTTCCCGCCGGACCGGGCAGGGCGCGAGCGCCTGGAACGCTCCTTCGACGCAGTGCTCCCCGCGCGCGGCGGCAAGGACGGAGCGCAGTCCCGCGCCGCGGTCCTGACGGTGGCGATGGCCGCACTGGTCCATCGATACACCGGGCTCGACCCGGTTCCCATCGACCTGCTCCACGGCAAGGAATCCGTCACCGTCACCGTCACCGTGACTGACGAGGCGAGCACCGCCGATCTCGTGGCGGAGCTGAGCGGCGTGCCACGGTCCCGGAGCGCACCCGGTCCCTTCGCCCTCGCGCTCACGGCCGACCCCGGTGCCGCGAGCACCGCGCACGGACAGGACGCCATACCCGGGAGGGAACTGGTCCTGTACGCGTACCAGGCCTCGCCGAAGGTGACGCTCAGTCTCGACGCCGCGCGATTCGACAACGCCTACGCCGACCGCGTCGCGGGACACTTCGAGGTCCTGCTCGCACAGATGGCGGACGCGCCGGACGCCCCCGTCACCCGCCTGAACATCCTGACGGCCGCGGAAGCCGACACCGTCCTGCGCGCGTGGAACGCCACGGACGCACAGGTCACGGAGGACATCTGCCTCCACCAGGCCTTCGAAGCGCGGGCCACGCGGGAACCCGACGCGGTGGCCGCCGTCTTCGGCGCGCAGTCGTGGTCCTTCGGCGCGGTGAACCGACGGGCCAACCAACTGGCCCACCGTCTCATCGAGTTCGGCGTGAGGCCGGACGTCAGGGTCGGGCTCCACCTCCACAAGACCCCGGACCTGCTGATCGCGATCCTTGGTGTCCTGAAGGCCGGCGGGGCCTATGTCCCTTTGGACCCGGCGTACCCCCAGGACCGTCTGGAGACCATGGTCGCCGGCACCGGCTGCGAGGTCATGATCAGCAGTCGGGGCCTTGACGGGACACTTTCCGCACGGGTGCGTCACCACCTGGTGCTGGACGAGCCGGGAAGTCTGCTCGACGGACCCACGGACAACCCGGTCACCGAGGTCCGCCCGGACAGCCTCTGCTACGTGATCCACACCTCGGGTTCCACCGGAACACCCAAGCCGATCGCCTTGTGCCACCGCGGCGTGCTCAACAACCTCGCGGACCTCAACACGAGGTACGGCGTGGGCTCCGAGGACGCGGTTCTCGCGCTGTCCTCGCCGAGCTTCGACATGTCGGTGTACGAGTTCCTCGGCATCATCCTCGCCGGTGGCACGGTCGTCATCCCGGACCAGGAGGCCGGACACCATCCGGCCTCCTGGTGGGAACTCGTCCACCGGCACCATGTCACGGTCTGGAACACGGCGCCGCCCCTGATCGAACTGTTCCTTGACCACGCGGAGATCAACGGCGACGGACGTCCGCTTCCGCTGAGACTCTGCATGACCGGCGGGGACTGGGTGCCGACGACGATGCCGGCGCGCTTCCGCAAGGTGGCACCCACCCTCAGGTTCGTGGCGCTGGGCGGCGCAACGGAGGCCTCCATCCACTCGACCGCCTACGAGTGGGACGCGGCCGAGGAGTGGAGCGGCGGGCACCTGCCCTACGGACGCCCTCTGGCGAACCAACGGACGTTCATCCTGGACGAGCGGATGATGCCGGTGCCCGTCGGCGTCCCCGGGGAGCTCTACCTCGCCGGCACCGGCCTGGCCCGTGGCTACCTCGGCCGCTCCCGGGACACCGGCGAGCGCTTCGTCCGGTGGTCCTTCGGCGACCGCTGTGCGGAACGCCTGTACCGGACAGGTGACATGGCGAAGTTCTGGCCCGACGGGCTGATCGAGATCCTCGGGCGGAAGGACTTCCAGGTAAAGATCAACGGGATCAGGGTCGAACTGGGGGAGATTGAGTCCGTCTTGGCCGCACACCCAGATGTCAGGCGCGCCGTGGTCGTCTCCCGCGCCGCAGAGGACGGGCACGTGACGCTGGCCGGATACGTCACCGCCCGGCGCGGCGGGACGCCGGACCGCGCGGCGCTGTTCGACGCACTGCGGGCACGGCTCCCGCAGCACATGATCCCCTCGTCGATCGAGATCGTGGAGTCGCTGCCCCTGAACAAGAACGGCAAAGTGGACCGCCGCGCGCTGAGTTCACCGGCGACGGCACACCCCGCCGTCGCGCCGGTGCCGGCCCGAGCGCGGACCGGAACCTGGCACCGCCTGGTCTCCGACGCGTGGTGCGACGTTTTGGGCGTCGACCACCTGGACGGACACGCCAACTTCTTCAACCACGGCGGGGACTCCATGAAAGCGATCAGGAGCATGGTGCGCATCGACCGCCGGCTGCGCGTCTCCGATATCTACGAGCACCCGACCGTGACCGCCCTGGCGGATCACCTGACCGAACGTTACGGCGAGCAACCGGGCGCCTAG	MNSADSTTQTASTQAASTQTAHASFPPGPGHRFPPDRAGRERLERSFDAVLPARGGKDGAQSRAAVLTVAMAALVHRYTGLDPVPIDLLHGKESVTVTVTVTDEASTADLVAELSGVPRSRSAPGPFALALTADPGAASTAHGQDAIPGRELVLYAYQASPKVTLSLDAARFDNAYADRVAGHFEVLLAQMADAPDAPVTRLNILTAAEADTVLRAWNATDAQVTEDICLHQAFEARATREPDAVAAVFGAQSWSFGAVNRRANQLAHRLIEFGVRPDVRVGLHLHKTPDLLIAILGVLKAGGAYVPLDPAYPQDRLETMVAGTGCEVMISSRGLDGTLSARVRHHLVLDEPGSLLDGPTDNPVTEVRPDSLCYVIHTSGSTGTPKPIALCHRGVLNNLADLNTRYGVGSEDAVLALSSPSFDMSVYEFLGIILAGGTVVIPDQEAGHHPASWWELVHRHHVTVWNTAPPLIELFLDHAEINGDGRPLPLRLCMTGGDWVPTTMPARFRKVAPTLRFVALGGATEASIHSTAYEWDAAEEWSGGHLPYGRPLANQRTFILDERMMPVPVGVPGELYLAGTGLARGYLGRSRDTGERFVRWSFGDRCAERLYRTGDMAKFWPDGLIEILGRKDFQVKINGIRVELGEIESVLAAHPDVRRAVVVSRAAEDGHVTLAGYVTARRGGTPDRAALFDALRARLPQHMIPSSIEIVESLPLNKNGKVDRRALSSPATAHPAVAPVPARARTGTWHRLVSDAWCDVLGVDHLDGHANFFNHGGDSMKAIRSMVRIDRRLRVSDIYEHPTVTALADHLTERYGEQPGA	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	147.66	gnl|BL_ORD_ID|4935|hsp_num:0	5928			591	1635	colistin A; colistin B
BGC0000953.1|Amicetin_19 # 22497 # 23561 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.668	BGC0000953.1|Amicetin_19 	22497	23561	+	Loose	200	31.9574	vanT gene in vanN cluster	28.57	3002975	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTCCGTCTATCTCGTGACCGGCGCCGCGGGTTTCATCGGCGCGAACTATGTGCAGCACCTGTTGGAGTGGGAGGCGTCGCACGCCGAAGTGATCGCGGTGGACTACCTGGGGTTCGCCGGAAACCAGGCGAACCTGGACTCGGTTGCCGACCGCGTCGTGTTCGAGAAGGCCGACATAGCCGACCTCGCCGCCATGGAAGAGATCTACCGGCGCTACCGGCCGGACTACGTCGTGAACTTCGCTGCCGAGTCGCACAACGACCGGGCAATCCTGGAACCGAGCGCGTTCATGCGGTCCAACGCGCTCGGGGCGCAGGTGATGGCCGAGTGCAGCCGACTGGTGCCCGTCAGGGCCCATGTCCACGTGTCGACGATCGAGGTCTACGGCGAACTGCCCCCTAGAGACCGGTGGTTCACCGAGCGCTCCCCGCTTAACGCCAAGACGCCCTACAGCGCGGCCAAGGCCGCGGGGGACCAGATCGTACGGGCCTACATGCAGACCTATCCAAACCTGGACATCCGGATGACGCACTGCGCGAACAACTACGGCCCGTACCAGCTGCCGGAGAAGCTGATCCCGCTGGCGGTGACGAACCTGCTGCGCGGCCGCAAGGTACCCGTGTACGGTGACGGCCTGCAGCGCCGTGACTGGCTGCACGTCGCCGATCACTGCGCCGCGGTGCACCGGGTGCTCCACGCCGACCTCGGGCCGGTGCCGGCGCAGGCGGCCACAGCGCCGGAGCTGCTGCCGGTCTTCGACGTATCCGCCCGCCACGAGGTCACCAACCTGGACATCGCCCGCCGCGTCGTCACCGCACTCGGCCTCGATCCGGAGGAGTGGATCGAGCACATCCCGGACCGGCCGAACCACGACCGCCGGTACCTGATCGACCCGGAGAAGATCGAGACCCGGCTAGGTTGGCGGCCGGAACGCGACTTCGACACTGGTCTGACCGAGACGGTCGAGTGGTACGTGGAGCACCGCACCTGGTGGGAACGGATCCTCGAAGAGAAGGGAGAACTCGGCTTCGACTGGAGCATGGTGAGTCAGGGGCCTGCATGA	MSVYLVTGAAGFIGANYVQHLLEWEASHAEVIAVDYLGFAGNQANLDSVADRVVFEKADIADLAAMEEIYRRYRPDYVVNFAAESHNDRAILEPSAFMRSNALGAQVMAECSRLVPVRAHVHVSTIEVYGELPPRDRWFTERSPLNAKTPYSAAKAAGDQIVRAYMQTYPNLDIRMTHCANNYGPYQLPEKLIPLAVTNLLRGRKVPVYGDGLQRRDWLHVADHCAAVHRVLHADLGPVPAQAATAPELLPVFDVSARHEVTNLDIARRVVTALGLDPEEWIEHIPDRPNHDRRYLIDPEKIETRLGWRPERDFDTGLTETVEWYVEHRTWWERILEEKGELGFDWSMVSQGPA	MKNVNTGINQFRLIAAFMVVAIHCFPFQSFSKTLDILITLTLFRTAVPFFLMVTGFYLIGPIATKRGYPAYLKIKKFLKKQVKLYVLATLIYLPLAFYSGVITFKTSVIQFFQLIFFEGVLYHLWYFPALILGVLIVYCLLQRFTLRQVLLVTFLFYLLCLGGDSWWGLARQIPVLEKSYQGIFTLMIHTRNGLFFAPFFLTLGASFHQSEWNMRTSKAKYFLLIASLGMLVESYLLHSFSSPKHDSAYLFLPVVMFFLFPLILNWQPTRVIADASTISLGIYVLHPYVIAVVHTLAKKITILNNSLIYYLCVSLLTSLIILYVHSKKKKTTKNQATFVPRTKKVLSKQAVIHNLAQINQVIPKTTKIMAVIKANAYGTDDTEFARILEQQGVDFFAVATIDEGIRLRENGIKSKILILGYTPSIRIKELAHYTLIQTIVSKEHAYSLNQQKIPISCHLKIDTGMHRLGVEPVVQEVSSLYRLPYLNIQGIYSHLGSADDRSDKGMKRTRKQISIFDYLLHELELQKIDVGVTHLQSSYGILNYPELVYDYVRPGILLYGYLSEHNGDSKINLNLQPILDVQALLVSKKWVAAGEYLGYSLDTKLVSPKLIGIVSIGYADGVPRELSHNEFYLAYQGQNLPQIGRICMDMLLVDLTDSPEIKVESQISIFPELEQTANQTNTLTNEIISRLGNRFYTEWS	50.57	gnl|BL_ORD_ID|4745|hsp_num:0	1983			669	858	vancomycin
BGC0000953.1|Amicetin_21 # 23665 # 24036 # 1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000953.1|Amicetin_21 	23665	24036	+	Loose	450	23.0978	rmtG	34.62	3002668	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGAGGATTTTCGAGGTCCTTGTTCCCGCACCAGCCGGAGGCACTTCCCAGGAGAAGATGCGTATTGGGTCCTATCCGCGTGTCCGTGTCGAGGGCGGTGGCCGCGGGGTCGCCTCGCAGGCCGGGTCGGTCCTGCCGGTCGAGACGCTCCGCAAGACCGGTCTGGATGCCGCTATATCGGCGGCACTTGCACCGTGGCGCATGCCGCGGGCGGTGCACAATCCTGCTGGACGTGGCGCTCGCGGGGGCCGCGGCGGCCCCACGCCGGTGCAGTTGTCTTCCTTGGCAGCCGATCCCCCGACGGGCCGCCGTCTGTGGCAATTGTCCGAACAACTCACCGACGTGCGGTTCCTGTCTTCGGTCACCTTCTAA	MRIFEVLVPAPAGGTSQEKMRIGSYPRVRVEGGGRGVASQAGSVLPVETLRKTGLDAAISAALAPWRMPRAVHNPAGRGARGGRGGPTPVQLSSLAADPPTGRRLWQLSEQLTDVRFLSSVTF	MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAEYRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYLQNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQSAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNELYYVLKEKQDGEAVRGGDSHRESE	46.59	gnl|BL_ORD_ID|1266|hsp_num:0	1382			369	504	amikacin; tobramycin; arbekacin; gentamicin A; gentamicin
BGC0000953.1|Amicetin_22 # 24325 # 24864 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=7bp;gc_cont=0.693	BGC0000953.1|Amicetin_22 	24325	24864	-	Loose	275	46.9802	AAC(6')-Isa	26.32	3002563	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTCCGATGAGATCAGGCTGCGCCCGGTGACCGCCGAAGATCTCGATCTGTTCGAGCGCGAGTTCAGCGGGCCAGAGGGAGCCGGCCCGTACCAGTGGTTCGGCTTCACGTCACAAGCCGGCCTGCGTCAGCAATTCAGGGAGACCGGCCTGCTCGGCCCCGACGGCGGCATGCTCTCCGTCACGGAAGCGGGCAGGACGGTAGGCCGGGTCGAATGGTTCACCGGCGCCTGGGGACGACCCGCCACCTCCACCTGCTGGAGTGTGGCCATCGGTCTGGTACCCGCCGCGCAGGGCCGCGGCATAGGCACCCAGGCGCAGCGACTGCTGGCCGGGTACCTCTTCGATCACACCAGGGTCGAACGGCTTCAGGCCTGGACGGACTGCGCCAACCTTGCCGAGCAGCGTGCGCTGGAGAAGGCGGGTTTCGTCCGGGAGGGCGTGCTGCGCTCCGCGCAGTGGCGCGGCGGCCAGTGGCACGATCAGGTCATCTTCTCCATGCTCCGCGCGGACCGACCCGGCGGCGATCCGGGACGGTGA	MSDEIRLRPVTAEDLDLFEREFSGPEGAGPYQWFGFTSQAGLRQQFRETGLLGPDGGMLSVTEAGRTVGRVEWFTGAWGRPATSTCWSVAIGLVPAAQGRGIGTQAQRLLAGYLFDHTRVERLQAWTDCANLAEQRALEKAGFVREGVLRSAQWRGGQWHDQVIFSMLRADRPGGDPGR	MELRGDDVVLRPVADGEGEVLDRIVREPEVAAWWSPPEDFAGMLAIVFEGEVVGAIQFYEETDPEFHHAGIDVFLTARHQGKGLGTDAVRTLARWLVAERGHHRLTIDPAAANTAAIRSYRKVGFRPVGIMRAYGRDHRTGRWQDALLMDLLADELT	114.01	gnl|BL_ORD_ID|886|hsp_num:0	967			15	456	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000953.1|Amicetin_23 # 25914 # 26009 # -1 # ID=1_23;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.573	BGC0000953.1|Amicetin_23 	25914	26009	-	Loose	500	20.7866	ANT(6)-Ia	50.0	3002626	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ACTAGTGGATCTCTGCTGATGTGGCCGAGCATGACTGTTTGTCACCAAAATCTCCCGCGCCCCTGCCTCCGCGGGCCTCCCTATCCAGTCAGCTGA	TSGSLLMWPSMTVCHQNLPRPCLRGPPYPVS	MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHLNQILRFELLRMMSWKVGIKTEFSLSVGKNYKYINKYIDEDLWNRLLSTYRMDSYENIWKSLFICHQLFREVSKEVAELLGFDYPEYGKNITRYTEDMYKKYVENDYF	10.80	gnl|BL_ORD_ID|841|hsp_num:0	914			708	738	streptomycin
